Article
The TLR4-TRIF pathway can protect against the development of experimental allergic asthma.
Immunology - 1 Sept 2017
Shalaby Karim H, Al Heialy Saba, Tsuchiya Kimitake, Farahnak Soroor, McGovern Toby K, Risse Paul-Andre, Suh Woong-Kyung, Qureshi Salman T, Martin James G
Abstract excerpt
The Toll-like receptor (TLR) adaptor proteins myeloid differentiating factor 88 (MyD88) and Toll, interleukin-1 receptor and resistance protein (TIR) domain-containing adaptor inducing interferon-β (TRIF) comprise the two principal limbs of the TLR signalling network. We studied the role of these adaptors in the TLR4-dependent inhibition of allergic airway disease and induction of CD4+ ICOS+ T cells by nasal...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
